The DOW broke a 10000 last week and has been rolling along much of 2009. Most of the large cap stem cell stocks have followed the market the past two weeks, but the others have moved sporadically. The sector is still looking for a catalyst.
- ThermoGenesis (KOOL) = Up 11%; KOOL's been trading in a tight range for 8 or 9 months. It has broke out yet, but it's worth keeping an eye on it.
- Bioheart Inc. (BHRT.OB) = Down -38%; This stock spiked at the beginning of September and has fallen ever since. Based on the chart, the fall isn't done.
Market Cap Over 50 Million
Aastrom Biosciences (ASTM) = Cur Price: $0.36; Down -13%
BioTime, Inc. (BTIM) = Cur Price: $4.66; Down -14%
Celgene Corp (CELG) = Cur Price: $56.42; Up 4%
Cytori Therapeutics (CYTX) = Cur Price: $3.69; Up 1%
Geron Corp (GERN) = Cur Price: $6.50; Up 3%
ThermoGenesis (KOOL) = Cur Price: $0.689; Up 11%
Osiris Therapeutics (OSIR) = Cur Price: $7.03; Up 8%
StemCell Inc. (STEM) = Cur Price: $1.60; Up 3%
Market Cap Under 50 Million
Advanced Cell Technology (ACTC.OB) = Cur Price: $0.119; Up 5%
Athersys Inc. (ATHX) = Cur Price: $1.16; Up 2%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.278; Down -13%
Bioheart Inc. (BHRT.OB) = Cur Price: $1.15; Down -38%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.006; Down -23%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $2.14; Down -3%
Neuralstem (CUR) = Cur Price: $1.54; Up 6%
International Stem Cell (ISCO.OB) = Cur Price: $0.72; Up 3%
MultiCell Technologies (MCET.OB) = Cur Price: $0.021; Down -9%
Pluristem Therapeutics (PSTI) = Cur Price: $1.14; Down -15%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.175; Down -27%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.0025; Down -24%
Catalyst(s):
Still, nothing has changed from the last few months.
- M&A (mergers and acquisitions) activity will be key.
Posts
